Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
收藏资源简介：
<b>Table S1</b> The inhibitory effects against HDACs, <i>in vitro</i> antiproliferative activity and/or <i>in vivo</i> anticancer efficacy of hydroxamic acid-azole hybrids <b>1-14</b><b>Table S2</b> The inhibitory effects against HDACs, <i>in vitro</i> antiproliferative activity and/or <i>in vivo</i> anticancer efficacy of hydroxamic acid-indole/isatin hybrids <b>15-25</b><b>Table S3</b> The inhibitory effects against HDACs, <i>in vitro</i> antiproliferative activity and/or <i>in vivo</i> anticancer efficacy of hydroxamic acid-pyridine hybrids <b>26-34</b><b>Table S4</b> The inhibitory effects against HDACs, <i>in vitro</i> antiproliferative activity and/or <i>in vivo</i> anticancer efficacy of hydroxamic acid-pyrimidine hybrids <b>35-43</b><b>Table S5</b> The inhibitory effects against HDACs, <i>in vitro</i> antiproliferative activity and/or <i>in vivo</i> anticancer efficacy of hydroxamic acid-quinazoline/quinazolinone hybrids <b>44-52</b><b>Table S6</b> The inhibitory effects against HDACs, <i>in vitro</i> antiproliferative activity and/or <i>in vivo</i> anticancer efficacy of hydroxamic acid hybrids <b>53-64</b><br>
